SCHEMBL9997386

SCHEMBL9997386

Cc1ccc(S(=O)(=O)Nc2cccc(C(=O)O)c2O)cc1C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
MEN1 O00255 6/20 0.62
KMT2A Q03164 6/20 0.62
HSD17B10 Q99714 5/20 0.62
LMNA P02545 1/20 0.62
KDM4E B2RXH2 2/20 0.56
MCOLN3 Q8TDD5 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
POLB P06746 1/20 0.56
HPGD P15428 4/20 0.53
GAA P10253 3/20 0.53
CYP1A2 P05177 1/20 0.53
WDR5 P61964 1/20 0.53
PFKFB4 Q16877 1/20 0.51
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
GFER P55789 1/20 0.49
TP53 P04637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ACLY P53396 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28637555 0.82 KMT2A (0.58) ALDH1A1MEN1KMT2AHSD17B10KDM4E
SCHEMBL9996881 0.82 ALDH1A1 (0.62) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL9997384 0.81 LMNA (0.67) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL9997012 0.79 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AHSD17B10KDM4E
SCHEMBL9999225 0.78 ALDH1A1 (0.80) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL9997303 0.77 GLO1 (0.54) MEN1KMT2AKDM4EPOLBGAA
SCHEMBL6079716 0.77 MEN1 (0.53) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL28637411 0.77 ACLY (0.55) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL9997531 0.77 KMT2A (0.66) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL2888830 0.76 KDM1A (0.54) ALDH1A1MEN1KMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161201-A1 BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2011-12-29 WO disclosed